InsidersTradesSigma
Discover the full directors' dealings record of 진양제약, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 진양제약 has recorded 1 public disclosures. Market capitalisation: €57.1bn. The latest transaction was filed on 5 March 2026 — Other. Among the most active insiders: 진양제약. Every trade is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations